SD

Suresh Dumala

Active Director Director DIN 10827609
DIN 10827609 First appointment May 2025 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value •••• Premium profile

About Suresh Dumala

Data last updated:

Suresh Dumala is a Director at Silantro Pharma Private Limited (since 2025). The company operates in Food And Beverages. Silantro Pharma Private Limited reported revenue of ₹31.4 Lakh (FY 2025).

DIN 10827609
Primary Designation Director
Industry Food And Beverages
First Appointment 22 May 2025
Oldest Company Age 5 yrs
Largest company Silantro Pharma Private Limited · ₹31.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Silantro Pharma Private Limited U24302TG2021PTC148844
Director22 May 20252021₹31.4 Lakh (FY 2025)Active

Board colleagues of Suresh Dumala

Directorship timeline

Open interactive timeline →
Silantro Pharma Private Limited
Premium access

Shareholding and investment profile for Suresh Dumala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Dumala

Suresh Dumala currently holds 1 directorship: Silantro Pharma Private Limited (Director, since 22 May 2025, revenue ₹31.4 Lakh (FY 2025)).

Suresh Dumala was first appointed on 22 May 2025 as Director at Silantro Pharma Private Limited.

The current boards of Suresh Dumala's companies include Gandla Sushma (Silantro Pharma Private Limited), Sangeetha Chettupally (Silantro Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available